CDK4/6 inhibition in locally advanced/metastatic chordoma (NCT PMO-1601)

Frohling, S; Barth, TF; Groschel, S; Folprecht, G; Richter, S; Mayer-Steinacker, R; Schultheiss, M; Moller, P; Bauer, S; Siveke, JT; Dettmer, S; Richter, D; Heining, C; Horak, P; Glimm, H; Jager, D; Von Kalle, C; Schlenk, R

ANNALS OF ONCOLOGY, 2017; 28 ( ):